Search Results for keywords:"Bethesda Maryland"

The National Center for Advancing Translational Sciences will hold closed meetings to review grant applications for a special panel on April 3, 2025. The meetings are closed to the public to protect confidential business information and personal privacy. They will be held virtually from 10:30 a.m. to 3:00 p.m. The review process will be overseen by Ming Yan, Ph.D., at the National Institutes of Health in Bethesda, Maryland.

The National Advisory Council on Alcohol Abuse and Alcoholism has announced a change to its previously scheduled meeting times. Initially set for April 17, 2025, from 11:00 a.m. to 12:30 p.m., the meeting will now occur from 12:30 p.m. to 2:00 p.m. The meeting will take place at the National Institutes of Health in Bethesda, Maryland, and is closed to the public. This adjustment was published in the Federal Register on March 21, 2025.

The National Institutes of Health (NIH) has announced a series of closed meetings to evaluate grant applications. These meetings are in accordance with federal guidelines that allow discussions to remain private, given the potential disclosure of sensitive information such as trade secrets or personal data. The series of meetings includes panels focusing on various topics, such as vascular and hematology, cell and molecular biology, cardiovascular science, infectious diseases, and more. Each meeting will be held virtually at the NIH facilities in Bethesda, Maryland, over several days in March 2021.

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting from March 10 to 12, 2021. This meeting is to review and evaluate grant applications and will not be open to the public due to the potential disclosure of confidential information, such as trade secrets and personal data. The meeting will take place via video at the National Institutes of Health in Bethesda, Maryland. For more information, contact Charlene J. Repique, Ph.D., the Scientific Review Officer.

The Center for Scientific Review under the National Institutes of Health announced a change to the meeting schedule for the Cancer Biology AREA/REAP Review Panel. Originally set to begin at 11:00 a.m. on April 8, 2025, the meeting will now start at 12:00 p.m. The meeting will be held at the NIH in Bethesda, Maryland, and it will not be open to the public.

The National Institutes of Health has announced a change to the meeting schedule for the National Advisory Council on Drug Abuse. Originally planned to start at 11:00 a.m. on February 9, 2021, the closed session will now begin at 10:45 a.m. and end at 12:30 p.m. The meeting will take place at the National Institute on Drug Abuse in Bethesda, Maryland. Part of the meeting will be closed to the public.

The National Center for Complementary and Integrative Health is hosting a meeting on April 11th and 14th, 2025, to evaluate grant applications for clinical trials of complementary and integrative interventions. This meeting will be closed to the public to protect confidential information and personal privacy. It will be conducted as a video-assisted meeting, and the address provided is in Bethesda, Maryland. The event is being organized under the Federal Advisory Committee Act.

The National Institute of Diabetes and Digestive and Kidney Diseases announced a closed meeting to be held on April 29, 2025, from 1:30 p.m. to 3:30 p.m. The meeting will review and evaluate cooperative agreement applications and is not open to the public to protect confidential trade secrets and personal information. This virtual meeting will occur at the NIH's location in Bethesda, Maryland, and individuals may contact Dr. Ann A. Jerkins for more information. This notice complies with the Federal Advisory Committee Act requirements.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development is holding a closed meeting on March 5, 2021, to review grant applications related to obstetrics and maternal-fetal biology. The meeting will take place from 10:00 a.m. to 6:00 p.m. at the National Institutes of Health in Bethesda, Maryland, but will be video-assisted. This meeting is closed to the public to protect confidential information and personal privacy.

The National Human Genome Research Institute announced a change in their upcoming Special Emphasis Panel meeting scheduled for April 22, 2025. The change involves assigning a new Scientific Review Officer because of staffing changes. This meeting is closed to the public and will take place at the NHGRI office in Bethesda, Maryland. This announcement was initially published on March 28, 2025, in the Federal Register.